Cargando…
Beneficial effects of erythropoietin in preclinical models of shock and organ failure
Erythropoietin protects many organs against the tissue injury and dysfunction caused by ischaemia/reperfusion and excessive inflammation. This editorial comment discusses the effects of erythropoietin in preclinical models of septic shock, endotoxemia, hemorrhagic shock, spinal cord trauma and zymos...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206404/ https://www.ncbi.nlm.nih.gov/pubmed/17543134 http://dx.doi.org/10.1186/cc5912 |
| _version_ | 1782148463882928128 |
|---|---|
| author | Thiemermann, Christoph |
| author_facet | Thiemermann, Christoph |
| author_sort | Thiemermann, Christoph |
| collection | PubMed |
| description | Erythropoietin protects many organs against the tissue injury and dysfunction caused by ischaemia/reperfusion and excessive inflammation. This editorial comment discusses the effects of erythropoietin in preclinical models of septic shock, endotoxemia, hemorrhagic shock, spinal cord trauma and zymosan-induced multiple organ failure. |
| format | Text |
| id | pubmed-2206404 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-22064042008-01-19 Beneficial effects of erythropoietin in preclinical models of shock and organ failure Thiemermann, Christoph Crit Care Commentary Erythropoietin protects many organs against the tissue injury and dysfunction caused by ischaemia/reperfusion and excessive inflammation. This editorial comment discusses the effects of erythropoietin in preclinical models of septic shock, endotoxemia, hemorrhagic shock, spinal cord trauma and zymosan-induced multiple organ failure. BioMed Central 2007 2007-05-29 /pmc/articles/PMC2206404/ /pubmed/17543134 http://dx.doi.org/10.1186/cc5912 Text en Copyright © 2007 BioMed Central Ltd |
| spellingShingle | Commentary Thiemermann, Christoph Beneficial effects of erythropoietin in preclinical models of shock and organ failure |
| title | Beneficial effects of erythropoietin in preclinical models of shock and organ failure |
| title_full | Beneficial effects of erythropoietin in preclinical models of shock and organ failure |
| title_fullStr | Beneficial effects of erythropoietin in preclinical models of shock and organ failure |
| title_full_unstemmed | Beneficial effects of erythropoietin in preclinical models of shock and organ failure |
| title_short | Beneficial effects of erythropoietin in preclinical models of shock and organ failure |
| title_sort | beneficial effects of erythropoietin in preclinical models of shock and organ failure |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206404/ https://www.ncbi.nlm.nih.gov/pubmed/17543134 http://dx.doi.org/10.1186/cc5912 |
| work_keys_str_mv | AT thiemermannchristoph beneficialeffectsoferythropoietininpreclinicalmodelsofshockandorganfailure |